TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

ROSEN, LEADING INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
ROSEN, LEADING INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX

Rosen Law Firm filed a class action lawsuit against Telix Pharmaceuticals for allegedly making false statements about prostate cancer therapeutic candidates and supply chain quality during February 21-August 28, 2025.

Insights
ALNY   neutral

Mentioned in licensing agreement for Leqvio, with no specific performance details provided


TLX   negative

Lawsuit alleges company made materially false and misleading statements about its prostate cancer therapeutic progress and supply chain quality, suggesting potential corporate misrepresentation